Sectoral Asset Management Inc Aveo Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.21 - $7.45 $157,113 - $188,485	-25,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.97 - $15.28 $6.72 Million - $17.2 Million	-1,125,875 Reduced 97.8%	25,300 $185,000
Q4 2020 Feb 12, 2021	BUY	$5.08 - $6.68 $5.34 Million - $7.02 Million	1,051,175 Added 1051.18%	1,151,175 $6.64 Million
Q3 2020 Nov 13, 2020	SELL	$4.16 - $6.26 $208,000 - $313,000	-50,000 Reduced 33.33%	100,000 $594,000
Q2 2020 Aug 13, 2020	BUY	$3.47 - $9.99 $520,500 - $1.5 Million	150,000 New	150,000 $773,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.